Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
With a market cap of 1.04T, Eli Lilly(LLY) trades at $1,107.32. The stock has a price-to-earnings ratio of 39.67 and currently yields dividends of 0.59%.
On 2026-06-23, Eli Lilly(LLY) stock moved within a range of $1,090.23 to $1,120.98. With shares now at $1,107.32, the stock is trading +1.6% above its intraday low and -1.2% below the session's peak.
Trading activity shows a volume of 2M, compared to an average daily volume of 3.15M.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,182.73 and a low of $623.78.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,182.73 and a low of $623.78.
LLY News
Sangamo Therapeutics Inc. (NASDAQ:SGMO) filed for Chapter 11 bankruptcy protection on Tuesday, as the gene therapy company seeks to sell its assets through a co...
Sangamo Therapeutics (SGMO) announced that it has commenced voluntary Chapter 11 bankruptcy reorganization proceedings and entered into separate “stalking horse...
Pharmaceutical giant Eli Lilly (LLY) is undertaking an innovative new strategy that will see it partner with scientists on new drug developments. Unlock powerf...
Analyst ratings
84%
of 32 ratingsMore LLY News
GLP-1 drugs are proving helpful for many conditions, not just weight loss. In studies, they have shown they can reduce cardiovascular risk, sleep apnea, and eve...
Key Points Viking Therapeutics has a weight-loss program that looks to be competitive with medicines already on the market. It's unclear how its candidate com...
Centessa (CNTA) which entered into a definitive agreement relating to its proposed acquisition by Eli Lilly (LLY), through a wholly owned subsidiary, announced...
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Eli Lilly didn't make the cut. Grab the names FREE today . Lilly secured f...
Berenberg analyst Kerry Holford raised the firm’s price target on Eli Lilly (LLY) to $1,135 from $1,050 and keeps a Hold rating on the shares. Unlock powerful...
Wall Street brokerage Cantor Fitzgerald is pounding the table on Eli Lilly’s (LLY) stock as we head into second-quarter earnings season. Unlock powerful invest...
Eli Lilly (NYSE:LLY) announced a new research and collaboration agreement with BioArctic AB to develop a neurodegeneration therapy using BioArctic's BrainTransp...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.